Peripheral neuropathy — all decisions

The Board denied service connection for a heart disability, to include IHD, but granted an earlier effective date of September 26, 2011, for the appellant's peripheral neuropathy of both upper extremities.

The Board granted a 30 percent rating for left and right lower extremity neuropathy, characterized by severe incomplete paralysis of the external popliteal nerve.

The Board granted service connection for diabetes mellitus, type II, hypertension, and prostate cancer as due to exposure to herbicides. It also granted service connection for erectile dysfunction, nephropathy, bilateral lower extremity peripheral neuropathy, bilateral upper extremity peripheral neuropathy, and diabetic retinopathy as secondary to the already service-connected conditions of diabetes mellitus or prostate cancer.

The Board granted service connection for back injury and syrinx/hydromyelia, reopened the claims based on new evidence, and denied increased ratings for fibromyalgia, blepharospasm, small fiber neuropathy with autonomic dysfunction, and cervical spondylosis.

The Board remands the claim for service connection for type II diabetes mellitus, peripheral neuropathy, and vision problems to the AOJ for adjudication of the request to substitute for accrued benefits purposes.

The Board granted a total disability rating based on individual unemployability (TDIU) and remanded several issues for further development, while dismissing or denying service connection for various conditions.

The Board granted service connection for peripheral neuropathy of the bilateral upper and lower extremities and asthma, to include dyspnea, based on presumed in-service toxic exposure.

The Board dismissed the appeal for service connection for diabetic neuropathy, depression, inability to sleep and panic attacks, flat feet, and plantar fasciitis as the Veteran withdrew her request.

The Board remands the claim for a right hip condition to ensure adequate VA opinions are obtained and clarify the Veteran's right hip disability(ies).

The appeal for service connection for neuropathy associated with diabetes is dismissed as the Veteran was granted service connection in an August 2025 rating decision.

The Board remands the case to the AOJ for further development and adjudication of the Veteran's claim for TDIU based on his right shoulder arthroplasty.

The appeal for service connection for peripheral neuropathy was withdrawn by the Veteran's attorney, and thus the appeal is dismissed.

The Board granted service connection for right and left lower extremity peripheral neuropathy of the femoral nerve, assigning a 20 percent rating effective June 9, 2025. The claim for TDIU was also granted.

The Board denied service connection for neuropathy of the left upper extremity as there is no evidence that it was incurred in or caused by service, and it did not manifest within one year of separation from service.

The Board granted an initial 100 percent rating for heart disease and special monthly compensation (SMC) based upon the need for regular aid and attendance of another person, while denying earlier effective dates for service connection for hypertension, heart disease, and left femoral nerve peripheral neuropathy.

The Board remands the claims for further development as there has not been substantial compliance with its prior remand directives.

The Board granted service connection for polyneuropathy of the left lower extremity, right lower extremity, left upper extremity and right upper extremity based on a finding that it is at least as likely as not that these conditions are related to the Veteran's exposure to Agent Orange during his service in Vietnam.

The Board granted a 10 percent initial rating for hypertension and denied higher ratings or service connection for the other conditions.

The Board granted service connection for bilateral lower extremities peripheral neuropathy, finding it at least as likely as not due to the Veteran's active service exposure to herbicides.

The Board denied increased ratings for PTSD, diabetes mellitus type II, left and right lower extremity peripheral neuropathy, and a TDIU.